Skip to main content
. 2022 Oct 25;9:905363. doi: 10.3389/fcvm.2022.905363

Figure 2.

Figure 2

CCs in the plaque aggravate NLRP3 expression and inflammatory cytokine secretion in patients with ACS. Comparison of levels of (A) NLRP3 mRNA expression, (B) serum IL-1β, and (C) serum IL-18 between the CCs group and the non-CCs group in patients with ACS. **P < 0.01 vs. the non-CCs group.